A detailed history of Savvy Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Savvy Advisors, Inc. holds 9,588 shares of ABBV stock, worth $1.72 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
9,588
Previous 5,993 59.99%
Holding current value
$1.72 Million
Previous $1.03 Billion 84.21%
% of portfolio
0.38%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$163.84 - $199.33 $589,004 - $716,591
3,595 Added 59.99%
9,588 $1.89 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $364,066 - $425,147
2,352 Added 64.6%
5,993 $1.03 Billion
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $215,117 - $245,106
1,346 Added 58.65%
3,641 $663 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $315,792 - $355,656
2,295 New
2,295 $356 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Savvy Advisors, Inc. Portfolio

Follow Savvy Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savvy Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Savvy Advisors, Inc. with notifications on news.